Team
We are a team of experts in molecular biology, regulatory management, and clinical development
R&D
Scientific Advisory Board
Keith Jerome, M.D., Ph.D.
Fred Hutchinson Cancer
Research Center
(Herpes Simplex Viruses, Hepatitis B)
John Baxter, M.D.
Cooper University Medical Center
(HIV Clinician)
Robert Bettiker, M.D.
Temple University School of Medicine
(HIV Clinician)
​
Rafik Samuel, M.D.
Temple University School of Medicine
(HIV Clinician)
Joseph Berger, M.D.
Perelman School of MedicineUniversity of Pennsylvania
(JC Virus & PML)
David Thomas, M.D.
Johns Hopkins School of Medicine
(Hepatitis B)
​
David Clifford, M.D.
Washington University School of Medicine in St. Louis
(PML and HIV)
Joseph Bondy-Denomy, Ph.D.
​University of California San Francisco
(CRISPR Inhibitors)
Frank Tufaro, Ph.D.
DNAtrix
(Herpes Simplex Viruses)
Kenneth L. Tyler, M.D.
University of Colorado Denver – Anschutz Medical Campus
(JC Virus & PML)
Timothy M. Block, Ph.D.
Baruch S. Blumberg Institute
(Hepatitis B)
​
Sam Jackson, M.D.
Alector
(Clinical Trialist)
Mark Kay, Ph.D.
Stanford University
(Viral Delivery)
Mike Walker, Ph.D.
Stanford University
(Bioinformatics)
Linda Law, M.D.
BioHealthConsult
(Regulatory & Clinical Expert)
Business Advisory Board
Annalisa Jenkins, M.B.B.S., F.R.C.P.
Biopharma & Life Sciences Executive
Jeff Kindler
CEO, Centrexion Therapeutics
Michael Marks
Founding Managing Partner, WRVI Capital
Paul Sekhri
President and CEO, eGenesis
​